CN106497903A - 一种用于纯化凝血酶原复合物的工艺 - Google Patents
一种用于纯化凝血酶原复合物的工艺 Download PDFInfo
- Publication number
- CN106497903A CN106497903A CN201610850251.8A CN201610850251A CN106497903A CN 106497903 A CN106497903 A CN 106497903A CN 201610850251 A CN201610850251 A CN 201610850251A CN 106497903 A CN106497903 A CN 106497903A
- Authority
- CN
- China
- Prior art keywords
- deae
- gels
- balance
- sephadex
- capto
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6432—Coagulation factor Xa (3.4.21.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/644—Coagulation factor IXa (3.4.21.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21022—Coagulation factor IXa (3.4.21.22)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610850251.8A CN106497903B (zh) | 2016-09-26 | 2016-09-26 | 一种用于纯化凝血酶原复合物的工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610850251.8A CN106497903B (zh) | 2016-09-26 | 2016-09-26 | 一种用于纯化凝血酶原复合物的工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106497903A true CN106497903A (zh) | 2017-03-15 |
CN106497903B CN106497903B (zh) | 2018-07-20 |
Family
ID=58290522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610850251.8A Active CN106497903B (zh) | 2016-09-26 | 2016-09-26 | 一种用于纯化凝血酶原复合物的工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106497903B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108048433A (zh) * | 2018-01-19 | 2018-05-18 | 贵州泰邦生物制品有限公司 | 一种人凝血酶原复合物的制备方法 |
CN108441490A (zh) * | 2018-04-02 | 2018-08-24 | 博雅生物制药集团股份有限公司 | 一种流动吸附法制备人凝血酶原复合物的工艺 |
CN108660126A (zh) * | 2018-06-08 | 2018-10-16 | 博雅生物制药集团股份有限公司 | 一种冻干人凝血酶的制备工艺 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101439047A (zh) * | 2007-11-20 | 2009-05-27 | 山东泰邦生物制品有限公司 | 提高人凝血酶原复合物稳定性fvii得率的工艺方法 |
CN103160486A (zh) * | 2013-04-02 | 2013-06-19 | 黑龙江迪龙制药有限公司 | 一种猪凝血酶的制备方法 |
CN104109202A (zh) * | 2014-07-17 | 2014-10-22 | 山东泰邦生物制品有限公司 | 一种从血浆中吸附人凝血酶原复合物的方法 |
CN105132399A (zh) * | 2015-09-28 | 2015-12-09 | 海安县华润食品有限公司 | 一种猪血提取血浆蛋白粉的方法 |
CN105175486A (zh) * | 2015-10-20 | 2015-12-23 | 上海洲跃生物科技有限公司 | 一种高纯人凝血因子ix的制备方法 |
CN105821025A (zh) * | 2016-04-06 | 2016-08-03 | 浙江丰安生物制药有限公司 | 一种凝血酶的提取方法 |
CN105879038A (zh) * | 2016-05-27 | 2016-08-24 | 成都蓉生药业有限责任公司 | 一种制备人凝血酶原复合物的干热处理稳定剂及其用途 |
-
2016
- 2016-09-26 CN CN201610850251.8A patent/CN106497903B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101439047A (zh) * | 2007-11-20 | 2009-05-27 | 山东泰邦生物制品有限公司 | 提高人凝血酶原复合物稳定性fvii得率的工艺方法 |
CN103160486A (zh) * | 2013-04-02 | 2013-06-19 | 黑龙江迪龙制药有限公司 | 一种猪凝血酶的制备方法 |
CN104109202A (zh) * | 2014-07-17 | 2014-10-22 | 山东泰邦生物制品有限公司 | 一种从血浆中吸附人凝血酶原复合物的方法 |
CN105132399A (zh) * | 2015-09-28 | 2015-12-09 | 海安县华润食品有限公司 | 一种猪血提取血浆蛋白粉的方法 |
CN105175486A (zh) * | 2015-10-20 | 2015-12-23 | 上海洲跃生物科技有限公司 | 一种高纯人凝血因子ix的制备方法 |
CN105821025A (zh) * | 2016-04-06 | 2016-08-03 | 浙江丰安生物制药有限公司 | 一种凝血酶的提取方法 |
CN105879038A (zh) * | 2016-05-27 | 2016-08-24 | 成都蓉生药业有限责任公司 | 一种制备人凝血酶原复合物的干热处理稳定剂及其用途 |
Non-Patent Citations (7)
Title |
---|
文圆: "人凝血酶原复合物的研究进展", 《微生物学免疫学进展》 * |
曹海军等: "凝血酶原复合物制备过程吸附条件的研究", 《中国输血杂志》 * |
曹海军等: "正交试验法优化凝血酶原复合物的制备工艺", 《中国生物制品学杂质》 * |
沈永才等: "影响凝血酶原复合物制备的几种因素", 《中国预防医学杂志》 * |
王建华等: "《科技资料汇编1991-1992》", 31 December 1992 * |
邢延涛等: "人凝血因子VIII原液生产工艺放大可行性研究", 《中国输血杂质》 * |
陶杰、陈梁军主编: "《生物制药工艺技术》", 28 February 2013, 中国医药科技出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108048433A (zh) * | 2018-01-19 | 2018-05-18 | 贵州泰邦生物制品有限公司 | 一种人凝血酶原复合物的制备方法 |
CN108048433B (zh) * | 2018-01-19 | 2020-07-21 | 贵州泰邦生物制品有限公司 | 一种人凝血酶原复合物的制备方法 |
CN108441490A (zh) * | 2018-04-02 | 2018-08-24 | 博雅生物制药集团股份有限公司 | 一种流动吸附法制备人凝血酶原复合物的工艺 |
CN108660126A (zh) * | 2018-06-08 | 2018-10-16 | 博雅生物制药集团股份有限公司 | 一种冻干人凝血酶的制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN106497903B (zh) | 2018-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105017412B (zh) | 一种从牛血清中分离高纯度牛血清白蛋白的方法 | |
CN106497903B (zh) | 一种用于纯化凝血酶原复合物的工艺 | |
CN104109202B (zh) | 一种从血浆中吸附人凝血酶原复合物的方法 | |
CN104513307B (zh) | 一种从大豆乳清中回收Kunitz及Bowman-Birk型胰蛋白酶抑制剂的方法 | |
JP2018502151A (ja) | 真珠タンパクの調製方法、該方法で調製される水溶性真珠タンパク及び酸可溶性真珠タンパク | |
BR112013022251B1 (pt) | Método para isolar osteopontina utilizando alimentos contendo cmp ou espécies de caseína | |
AU596159B2 (en) | Method and apparatus for separating proteins | |
CN104672328A (zh) | 一种人抗凝血酶ⅲ的生产方法 | |
JP2018518192A (ja) | ブロッコリータンパク質のペプチドを調製する方法、それによって調製されたブロッコリータンパク質のペプチド、および、その使用 | |
JPS6147187A (ja) | 狂犬病ウイルスの精製方法 | |
CN108048433B (zh) | 一种人凝血酶原复合物的制备方法 | |
CN106676089B (zh) | 一种从血浆中制备人凝血酶原复合物的方法 | |
CN107827974A (zh) | 一种人纤维蛋白原的制备方法 | |
CN107337727A (zh) | 一种血源性人凝血因子ⅷ制备方法 | |
CN105326859A (zh) | 一种从Cohn血浆组分III中制备人凝血酶原复合物的方法 | |
CN110257358A (zh) | 一种高纯人凝血因子ix制剂的生产方法 | |
CN111530439B (zh) | 一种制备血清中定值梅毒特异性抗体的方法 | |
CN109705208A (zh) | 一种单步层析制备高纯度血管性血友病因子的工艺 | |
CN112410323B (zh) | 一种羔羊皱胃凝乳酶标准品的制备方法 | |
CN108410936A (zh) | 一种水牛乳抗氧化肽及其分离制备方法 | |
CN104280498A (zh) | 一种乳制品中乳铁蛋白的检测试剂盒及检测方法 | |
Casillas et al. | Chromatographic behaviour of clotting factors | |
CN103393102A (zh) | 一种胶原多肽口服液的制备方法 | |
CN104928337A (zh) | 马面鲀鱼皮锌螯合肽 | |
Taylor et al. | An improved procedure for the preparation of human serum albumin from placental extracts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wei Shu Inventor after: Zhai Xiaofeng Inventor after: Cao Haijun Inventor after: Zhou Min Inventor after: Li Changqing Inventor after: Chen Jiting Inventor after: Su Yansun Inventor after: Wei Jiaxu Inventor before: Wei Shu Inventor before: Zhai Xiaofeng Inventor before: Cao Haijun Inventor before: Zhou Min Inventor before: Li Changqing Inventor before: Chen Jiting Inventor before: Su Yansun |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 050200 No. 6, Qingshan Road, Luquan Green Island Torch Development Zone, Shijiazhuang, Hebei Patentee after: Bohui Biopharmaceutical (Hebei) Co.,Ltd. Patentee after: CHINESE ACADEMY OF MEDICAL SCIENCE PEKING UNION MEDICAL College INSTITUTE OF BLOOD TRANSFUSION CHENGDU CHINA Address before: No.6, Qingshan Road, Luquan Green Island Torch Development Zone, Shijiazhuang City, Hebei Province 050221 Patentee before: HEBEI DAAN PHARMACY CO.,LTD. Patentee before: CHINESE ACADEMY OF MEDICAL SCIENCE PEKING UNION MEDICAL College INSTITUTE OF BLOOD TRANSFUSION CHENGDU CHINA |